Natural Language Processing Improves Risk Signal Documentation in Clinical Trials
Authors: Sylviane de Viron, Data and Knowledge Manager Nicolas Huet, Machine Learning Manager Central monitoring helps sponsors proactively identify quality issues in clinical trials. To…
Read More
Federated Learning & Risk-Based Data Management – The Future of Smart Healthcare
According to CluePoints Senior Vice President John Hall, “Federated learning is a critical evolution in the application of machine learning (ML) in healthcare and clinical…
Read More
Industry-leading Risk-Based Quality Management event focuses on the maturity of RBQM, its increasing value, and the vision for the future
CluePoints Hosts RBQM Live 2022 as the Premier Event Sponsor King of Prussia, PA – Aug 30th, 2022: Industry-leading risk-based study execution and data quality…
Read More
The best of both: The key reasons to outsource RBQM tech but keep data control
You can outsource the work, but you can’t outsource the responsibility – so should you outsource Risk-Based Quality Management (RBQM)? It’s a question pharma companies…
Read More
What’s in Store at the Industry’s Leading, 100% Virtual RBQM Event?
Risk-based quality management (RBQM) supports enhanced quality oversight for the entire clinical trial lifecycle, increasing the efficiency and timeliness of clinical trials and driving accelerated…
Read More
10 Reasons Why CROs Leverage CluePoints for RBQM
Written by Andrea McSweeney, Vice President of Customer Success – Channel, CluePoints Contract research organizations (CROs) are uniquely positioned to partner with sponsors on risk…
Read More
CluePoints to Share Case Study on Technology ROI at The SCDM 2022 EMEA Leadership Forum & Conference
Decentralized clinical trials (DCTs) have become a buzzphrase in recent years, with commentators lining up to extol the benefits of this new way of working.…
Read More
Join us at DIA 2022 as we Demystify the De-risking of DCTs
The world of decentralized clinical trials (DCTs) and risk-based quality management is evolving rapidly – but CluePoints and our partners are here to help you…
Read More
Events
Find out where we’re headed next.
Featured Whitepaper
ICH E6 (R2)
Summary
Paper
Created in conjunction with our peers at TUFTS Center for the Study of Drug Development, this paper provides insights on how companies are responding to ICH E6 (R2) and information on the key themes on adoption.
Featured Webinar
ICH E6 (R2)
Webinar
Series
This recorded webinar covers all of the frequently asked Questions about ICH E6 (R2), Risk-Based Study Execution (RBx) and what’s required from a people, process & technology standpoint.
We're Kind of a Big Deal.
3,400
Platform Users
700
Studies De-Risked
64,000
Issues Detected
